When evaluated on protein level in sarcoma cell lines, the three tested antibodies demonstrated substantial variations in the detection of BRD4 isoforms while there was no apparent difference between cell lines (Fig. 4B and Fig. S4A). This evidence concerns the gene BRD4 and sarcoma.